Skip to main content
RHEP logo

RHEP · Regional Health Properties, Inc

Track RHEP — free
$1.07 +0.02 (+1.90%) At close · Aug 31
Market Cap
$4.12M
Shares
3.92M

Price & Indicators

20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$1.07 Open$1.07 Day$1.07–1.07 52W close$1.00–2.00 Avg vol 30d2K Short int7K · 0.2% float · 6.0d Short vol68% DataJan 2020–Aug 2026 Filing10-Q · Aug 12

Up next

FQ3-26 quarter ends
~Sep 30, 2026 Est
filed Aug 12, 2026

Equibles Rating

blended score · not investment advice
Overall
Sell
SellHoldBuy
Technical Sell Momentum Weak Sentiment Neutral Fundamentals Fair Quant / Vol Very High
Market backdrop VIX 14.9 · calm Equity put/call 0.70
Technical
price trend
Sell
50 / 200-day cross No cross
Price vs 200-day avg −17%
below
Price vs 50-day avg −2%
below
RSI (14) 50
neutral
MACD trend Positive
52-week position 7%
near low
Momentum
relative strength
Weak
1-month return +5%
trailing
6-month return −18%
trailing
YTD return −16%
this year
Relative strength −31%
vs S&P · 6-mo
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50d $1 › 200d $1 — 200d above 50d
Institutional flow Flat
0% holders QoQ
Insider flow Distributing
Net -$106 over 90 days · 50% sells
Short interest Falling
0.18% of float · ▼ -1.5% MoM · 6.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr low
8 holders — near 3-yr low, contrarian setup
Squeeze score 49
elevated · 0–100
Fundamentals
Fair
Revenue growth +190%
Y/Y
EPS growth +163%
Y/Y
Free cash flow $-3.1M
Balance sheet $40.2M
net debt
Quant / Vol
risk profile
Very High
Volatility 87%
annualized · 1-yr
Max drawdown −71%
past year
ATR 6.0%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Technicals

trend & momentum for long-term holders Sell
2 · 3 · 1
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
−17% Bearish
Price vs 50-day avg
−2% Neutral
RSI (14)
50 Neutral
MACD trend
Positive Bullish
52-week position
7% Bearish
Market signals — smart money & positioning
Mixed
Trend (MA cross) No cross
50d $1 › 200d $1 — 200d above 50d
Institutional flow Flat
0% holders QoQ
Insider flow Distributing
Net -$106 over 90 days · 50% sells
Short interest Falling
0.18% of float · ▼ -1.5% MoM · 6.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr low
8 holders — near 3-yr low, contrarian setup
Price context
position in its 52-week range
Range low $1 Now $1 · 7% Range high $2
vs 200-day avg -17% vs 50-day avg -2%

Illustrative technical + ownership context — a signal mix, not investment advice.

Versus peers

Medical Care Facilities — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
RHEP
Regional Health Properties, Inc
this stock
$4.12M -16.4% +189.9% 0.2%
HCA
HCA Healthcare, Inc.
$92.69B -11.2% +7.1% 14.4 2.8%
FSNUY
Fresenius SE & Co. KGaA
$30.05B -8.0% 0.0%
THC
Tenet Healthcare Corp
$21.48B +33.8% +0.9% 10.3 3.1%
FMS
Fresenius Medical Care AG
$12.29B -4.5% +5.9% 0.5%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Accumulating
Holders
8
% held
0.7%
Net QoQ
+6.9K sh
Top holder
VANGUARD GROUP INC
Held Float
View
Short & Settlement
Short Interest Falling
Shares short
6.9K
Days to cover
6.0d
Change
-105 sh
View
Short Volume
Short vol %
68%
As of
Aug 31, 2026
Short Total
View
Fails to Deliver
FTD shares
30
Value
$32
As of
Aug 4, 2026
View
Off-Exchange
Off-exchange %
100.0%
Week of
Jul 27, 2026
Off-exch Lit
View
Smart Money
Insider Trades Net selling
Net (90d)
-$106
Buyers / Sellers
1 / 1
Buyers Sellers
View
Financials
Financials
Revenue (FY)
$53.2M
Net income (FY)
$-3.9M
EPS diluted
$1.09
View
Buybacks
Authorized
shares 500.0K
View
Filings
SEC Filings
Latest
10-Q
Filed
Aug 12, 2026
This year
8
View

Performance

5D 20D 120D MTD YTD
RHEP -7.0% +4.9% -18.0% +2.2% -16.4%
SPY +0.5% +1.2% +13.3% +2.7% +12.5%
vs SPY -7.4% +3.7% -31.3% -0.5% -28.9%

Capital returns

Buyback program · as of Nov 25, 2025
Authorized
shares 500,000
Spent (derived)
Remaining

Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

Key facts CIK 1004724 CUSIP 75903M309 13F (30d) 1 filings 1 filers Visit website